MELVITA ALLEN: Open Payments
NPI 1376103697 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 80 payments from 19 companies in 2025. Trend: 2023 $490 · 2024 $1,038 · 2025 $2,447
Food & beverage: $2,447
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 8 | $270 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $231 |
| United Therapeutics Corporation | 6 | $230 |
| SCPHARMACEUTICALS INC. | 4 | $209 |
| CVRx, Inc. | 1 | $209 |
| Merck Sharp & Dohme LLC | 8 | $178 |
| Abbott Laboratories | 1 | $166 |
| AstraZeneca Pharmaceuticals LP | 7 | $166 |
| Novartis Pharmaceuticals Corporation | 8 | $153 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $121 |
Products named: AMVUTTRA, Kerendia, FUROSCIX, Barostim Neo System, MITRACLIP, LEQVIO, VERQUVO, LifeVest.
Industry payments across FL — which companies pay providers there.
